Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,059 | -88,447 | -84,713 | -97,090 | -49,045 |
| Depreciation Amortization | -3,612 | 10,425 | -205 | 551 | 429 |
| Accounts receivable | 567 | -938 | 256 | 4,181 | -3,589 |
| Accounts payable and accrued liabilities | -1,859 | -2,734 | 2,770 | 1,422 | 594 |
| Other Working Capital | 4,478 | -8,274 | 14,111 | -251 | -4,512 |
| Other Operating Activity | 15,637 | 14,158 | 5,195 | 12,949 | 21,817 |
| Operating Cash Flow | $-79,848 | $-75,810 | $-62,586 | $-78,238 | $-34,306 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,386 | 13,779 | -73,273 | 99,835 | -71,883 |
| PPE Investments | N/A | -47 | -126 | -12,117 | -204 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -195 | -139 |
| Other Investing Activity | 0 | 0 | 0 | -195 | -138 |
| Investing Cash Flow | $-28,386 | $13,732 | $-73,399 | $87,523 | $-72,226 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 632 |
| Common Stock Issued | 10,894 | 86,929 | 57,297 | 65,216 | 213,487 |
| Other Financing Activity | -850 | -824 | -516 | -118 | -632 |
| Financing Cash Flow | $10,044 | $86,105 | $56,781 | $65,098 | $213,487 |
| Beginning Cash Position | 135,158 | 111,131 | 190,335 | 115,952 | 8,997 |
| End Cash Position | 36,968 | 135,158 | 111,131 | 190,335 | 115,952 |
| Net Cash Flow | $-98,190 | $24,027 | $-79,204 | $74,383 | $106,955 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,848 | -75,810 | -62,586 | -78,238 | -34,306 |
| Capital Expenditure | N/A | -47 | -126 | -12,117 | -204 |
| Free Cash Flow | -79,848 | -75,857 | -62,712 | -90,355 | -34,510 |